Addgene Inc.
Watertown, MA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- 490 Arsenal Wy Suite 100B, Watertown, MA 02472, USA
- Website
- addgene.org
- Founded
- 2004
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $513 |
| FY2025 | $1,345 |
| FY2024 | $2,005 |
| FY2023 | $2,037 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of the Navy | $513 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nabor: a sustainable, high-quality neuroscience antibody open resource | National Institute of Neurological Disorders and Stroke (NIH) | $10,564,140 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of California, Davis | U24NS109113 | $259,593 | |
| Massachusetts Institute Of Technology | UM1MH134812 | $465,019 | |
| Rector & Visitors Of The University Of Virginia | R01MH135905 | $129,222 | |
| The Broad Institute, Inc. | UF1MH130701 | $356,306 | |
| The Broad Institute, Inc. | UF1MH130701 | $181,206 |
Similar vendors
About the company
Addgene Inc., a tax-exempt nonprofit biorepository based in Watertown, Massachusetts, distributes plasmids, antibodies, and engineered viral vectors (AAV tools) to federal research agencies and grant-funded academic institutions as a prime grant recipient (88% of recent awards) and through small-value purchase orders. Addgene does not hold prime contract vehicles; instead, it receives plasmid purchase orders directly from federal agencies and participates as a sub-recipient on federally funded research grants awarded to universities and research institutes.
Addgene's federal customer base concentrates heavily on neuroscience and molecular biology research funding. The Office of Naval Research accounts for seven plasmid purchase orders totaling roughly $6 thousand in combined potential value — these are transactional purchases of specific plasmids (Addgene catalogue numbers including #83485, #83545, and others) for Navy-sponsored research programs, each typically $100 to $2,000 in ceiling value. The National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke together account for six awards, primarily grant sub-awards. These three agencies cover 49% of Addgene's combined potential value across all federal sources. Addgene's primary NAICS footprint is Research and Development in Biotechnology (except Nanobiotechnology), with procurement routing predominantly through PSC codes for Laboratory Equipment and Supplies and Chemicals.
Recent grant sub-awards show Addgene's role in neuroscience infrastructure. Under a University of Virginia sub-award (May 2025), Addgene validates and distributes re-engineered Cre-dependent AAV tools, packages DNA sequences into ready-to-use AAV particles, and conducts quality control including next-generation sequencing and droplet digital PCR validation before distributing to the global research community via its established cold-chain network and Data Hub platform. MIT (September 2025) and UC Davis (November 2025) sub-awards engage Addgene in antibody creation, storage, and distribution and in molecularly defined immunoprobes for brain protein mapping. Sub-awards from the Broad Institute (October 2024 and December 2023) involve enhancer identification for neuronal cell-type targeting. Activity has remained modest but steady — one to four awards per year over the past five years — with $11.8 million in dollars obligated against a $12 thousand combined potential value, indicating that actual invoiced revenue substantially exceeds the ceiling estimates recorded in procurement system snapshots. Recent plasmid purchase orders from ONR (February, December 2024, and March 2026) demonstrate ongoing transactional Navy engagement.
Quick answers
Is Addgene Inc. registered in SAM.gov?
Yes. Addgene Inc.'s SAM.gov registration is active through May 4, 2027.
What is Addgene Inc.'s CAGE code?
Addgene Inc.'s CAGE code is 49WN3, and its Unique Entity ID (UEI) is NJKHH48EZVF3.
How much has Addgene Inc. received in federal contracts?
Federal contracts obligated $1,345 to Addgene Inc. in fiscal year 2025 and $5,900 in fiscal years 2023 through 2027.
What is Addgene Inc.'s most recent federal award?
Addgene Inc.'s most recent federal contract award is Plasmid purchase for research purposes (N0017326P5418), from Office of Naval Research (SECNAV), on March 9, 2026.
On GovTribe
See Addgene Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors